Modabbernia, Amirhossein

Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses

Modabbernia, A., Velthorst, E., & Reichenberg, A. (2017) · Molecular Autism

Autism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

Cited by 809

Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies

Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 596

Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial

Shahidi, M., Mojtahed, A., Modabbernia, A., Mojtahed, M., Shafiabady, A., Delavar, A., & Honari, H. (2011) · International Journal of Geriatric Psychiatry

Humor Studies and ApplicationsPhysical Activity and Health

Cited by 200

Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

Sepanjnia, K., Modabbernia, A., Ashrafi, M., Modabbernia, M.-J., & Akhondzadeh, S. (2012) · Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 153

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

Ghaleiha, A., Entezari, N., Modabbernia, A., Najand, B., Askari, N., Tabrizi, M., Ashrafi, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Journal of Psychiatric Research

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 152

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology

Ovarian function and disordersTreatment of Major Depression

Cited by 116

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani, M.-R., Mirshafiee, O., Farokhnia, M., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Rezaei, F., Salehi, B., Yekehtaz, H., Ashrafi, M., et al. (2014) · Psychiatry Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 104

Aspirin for treatment of lithium‐associated sexual dysfunction in men: randomized double‐blind placebo‐controlled study

Saroukhani, S., Emami‐Parsa, M., Modabbernia, A., Ashrafi, M., Farokhnia, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Bipolar Disorders

Sexual function and dysfunction studiesBipolar Disorder and Treatment

Cited by 59

Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study

Jafarinia, M., Mohammadi, M., Modabbernia, A., Ashrafi, M., Khajavi, D., Tabrizi, M., Yadegari, N., & Akhondzadeh, S. (2012) · Human Psychopharmacology: Clinical and Experimental

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 42

Environmental exposure to metals, neurodevelopment, and psychosis

Modabbernia, A., Arora, M., & Reichenberg, A. (2016) · Current Opinion in Pediatrics

Heavy Metal Exposure and ToxicityTrace Elements in Health

Cited by 28